Authors:
DRESCHER KM
RIVERAQUINONES C
LUCCHINETTI CF
RODRIGUEZ M
Citation: Km. Drescher et al., FAILURE OF TREATMENT WITH LINOMIDE OR ORAL MYELIN TOLERIZATION TO AMELIORATE DEMYELINATION IN A VIRAL MODEL OF MULTIPLE-SCLEROSIS, Journal of neuroimmunology, 88(1-2), 1998, pp. 111-119
Citation: Cf. Lucchinetti et al., PARANEOPLASTIC AND ONCOLOGIC PROFILES OF PATIENTS SEROPOSITIVE FOR TYPE-1 ANTINEURONAL NUCLEAR AUTOANTIBODIES, Neurology, 50(3), 1998, pp. 652-657
Authors:
LUCCHINETTI CF
BRUCK W
PARISI J
SCHEITHAUER B
RODRIGUEZ M
LASSMANN H
Citation: Cf. Lucchinetti et al., PATTERNS OF MULTIPLE-SCLEROSIS IMMUNOPATHOLOGY, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 79-79
Citation: Cf. Lucchinetti et M. Rodriguez, THE CONTROVERSY SURROUNDING THE PATHOGENESIS OF THE MULTIPLE-SCLEROSIS LESION, Mayo Clinic proceedings, 72(7), 1997, pp. 665-678
Authors:
LUCCHINETTI CF
KIMMEL DW
PAVELKO K
RODRIGUEZ M
Citation: Cf. Lucchinetti et al., 5-FLUOROURACIL AND LEVAMISOLE EXACERBATE DEMYELINATION IN SUSCEPTIBLEMICE INFECTED WITH THEILERS VIRUS, Experimental neurology, 147(1), 1997, pp. 123-129
Authors:
LUCCHINETTI CF
BRUCK W
RODRIGUEZ M
LASSMANN H
Citation: Cf. Lucchinetti et al., DISTINCT PATTERNS OF MULTIPLE-SCLEROSIS PATHOLOGY INDICATES HETEROGENEITY IN PATHOGENESIS, Brain pathology, 6(3), 1996, pp. 259-274
Citation: Cf. Lucchinetti et Va. Lennon, NEUROLOGIC AND ONCOLOGIC CORRELATIONS IN PATIENTS SEROPOSITIVE FOR TYPE-2 ANTINEURONAL NUCLEAR AUTOANTIBODIES, Neurology, 46(2), 1996, pp. 1049-1049
Citation: Cf. Lucchinetti et al., DEVELOPMENT OF AN ANIMAL-MODEL FOR MULTIFOCAL INFLAMMATORY DEMYELINATION INDUCED BY 5-FLUOROURACIL AND LEVAMISOLE, Neurology, 45(4), 1995, pp. 462-462